Chronic News and Research

RSS

Twelve institutions receive NPCRC and American Cancer Society grants for palliative care research

The American Cancer Society and the National Palliative Care Research Center (NPCRC) are awarding $2 million in research grants to researchers at 12 institutions for studies aimed at reducing suffering for seriously ill patients and their family caregivers.

22 Jun 2011

Planning for changes in lifestyle, health leads to better retirement

Retirement is often viewed as a time to relax, travel, participate in leisurely activities and spend time with family. However, for many older adults, chronic health problems and poor planning often hinder the enjoyment of retirement.

22 Jun 2011

Medivir initiates TMC649128 phase Ib trial in chronic hepatitis C

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announces the start of a phase Ib clinical trial with TMC649128 intended for the treatment of chronic hepatitis C virus (HCV) infection.

22 Jun 2011

Pycnogenol, CoQ10 combination boost heart function

A recent study published in Panminerva Medica reveals that a Pycnogenol and Coenzyme Q10 combination taken by stable heart failure patients as an adjunct to medical treatment naturally strengthens the heart, increasing the blood volume ejected with each beat.

22 Jun 2011

Pfizer Lyrica Phase 3 study on Central Neuropathic Pain meets primary endpoint

Pfizer Inc. announced today that top-line results for Lyrica Study A0081107 - Central Neuropathic Pain Following Spinal Cord Injury - demonstrated that the study met its primary endpoint: positive efficacy in reducing Central Neuropathic Pain following Spinal Cord Injury with Lyrica compared to placebo.

22 Jun 2011

Research focuses on how marijuana affects decision-making process

Smoking marijuana affects peoples' impulsivity, attention, memory, cognition and decision-making abilities. That's been scientifically proven.

22 Jun 2011

Scientists discover molecular mechanism that could help develop new MS treatments

Scientists at The University of Nottingham have discovered a molecular mechanism which could bring about the development of new treatments for Multiple Sclerosis (MS) — a chronic inflammatory disease of the central nervous system.

22 Jun 2011

Study finds high prevalence of diabetic kidney disease in the U.S.

Over the past 2 decades the prevalence of diabetic kidney disease in the U.S. increased in direct proportion to the prevalence of diabetes itself, according to a study in the June 22/29 issue of JAMA.

22 Jun 2011

Millennium Labs founder receives Ernst & Young award in Life Sciences category

Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today that James Slattery, CEO and founder, has received the Ernst & Young Entrepreneur of the Year 2011 San Diego Award in the Life Sciences category.

21 Jun 2011

Respira reports results of DPI drug engine clinical study against COPD, asthma

Respira Therapeutics, a product development company focused on inhaled therapeutics to improve patients' lives, today announced the results of a clinical feasibility study of the Company's drug engine technology.

21 Jun 2011

New anti-abuse formulation of painkiller Oxycodone

It has come to health officials’ attention nationwide that there is a serious rise of abuse of painkillers, especially opioids. Federal officials recently stepped up plans to monitor frequent prescribers and users.

21 Jun 2011

California-born Asian and Pacific Islander women face higher risks of breast cancer

Young Asian and Pacific Islander women born in California have higher risks of breast cancer than young white women, and some groups, including Filipinas, might have higher risks than African-Americans, according to a new study that challenges the perception that these women are at a much lower risk of breast cancer than white women.

21 Jun 2011

FDA's draft guidance document addresses artificial pancreas system for type 1 diabetes

The U.S. Food and Drug Administration today issued draft guidance that will help advance the development and approval of an artificial pancreas system to treat type 1 diabetes in the United States.

21 Jun 2011

Wayne State team receives $330,000 NSF grant to develop 3-D neural probe for tinnitus

A team of Wayne State University researchers was awarded $330,000 from the National Science Foundation (NSF) to develop a 3-D neural probe. Their aim is to develop an implantable device that will suppress tinnitus, a neurological disorder that affects more than 250 million people worldwide.

21 Jun 2011

Study sheds new light on body's immune response to hepatitis A, C viruses

A surprising finding in a study comparing hepatitis C virus (HCV) with hepatitis A virus (HAV) infections in chimpanzees by a team that includes scientists from the Texas Biomedical Research Institute sheds new light on the nature of the body's immune response to these viruses.

21 Jun 2011

Insight into why some people develop drug addiction

Researchers at the University of Cambridge have identified abnormal brain structures in the frontal lobe of cocaine users' brains which are linked to their compulsive cocaine-using behaviour. Their findings were published today, 21 June, in the journal Brain.

21 Jun 2011

Amylin to present data on investigational diabetes drug candidates at ADA annual meeting

Amylin Pharmaceuticals, Inc. today announced that the Company will present data for its two first-in-class diabetes drugs, BYETTA injection and SYMLIN injection, and its investigational diabetes drug candidates BYDUREON and exenatide once monthly at the 71st Scientific Sessions of the American Diabetes Association (ADA) being held in San Diego, CA from June 24 to June 28.

21 Jun 2011

Roundup: State employee benefit battles heat up; Wis. Gov. to remake Medicaid program; Mass. cost controls

The Legislature is close to wrapping up its work on the $25 billion state budget bill after the Senate made minor changes to the plan late Sunday before approving it by a lopsided margin. ... the spending plan for the budget year that starts July 1 would eliminate more than 2,000 state jobs and includes cuts in most state departments and agencies.

21 Jun 2011

Benitec’s pain program validated by independent study

Benitec Ltd (ASX:BLT), a world leader in RNA-based gene silencing for human therapeutics, announced that China-based researchers have proved the concept behind Benitec's in house neuropathic pain program.

20 Jun 2011

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Pfizer Inc. and Acura Pharmaceuticals Inc. announce the marketing approval from the U.S. Food and Drug Administration (FDA) of OXECTATM Tablets CII.

20 Jun 2011

Chronic News and Research

Twelve institutions receive NPCRC and American Cancer Society grants for palliative care research

Planning for changes in lifestyle, health leads to better retirement

Medivir initiates TMC649128 phase Ib trial in chronic hepatitis C

Pycnogenol, CoQ10 combination boost heart function

Pfizer Lyrica Phase 3 study on Central Neuropathic Pain meets primary endpoint

Research focuses on how marijuana affects decision-making process

Scientists discover molecular mechanism that could help develop new MS treatments

Study finds high prevalence of diabetic kidney disease in the U.S.

Millennium Labs founder receives Ernst & Young award in Life Sciences category

Respira reports results of DPI drug engine clinical study against COPD, asthma

New anti-abuse formulation of painkiller Oxycodone

California-born Asian and Pacific Islander women face higher risks of breast cancer

FDA's draft guidance document addresses artificial pancreas system for type 1 diabetes

Wayne State team receives $330,000 NSF grant to develop 3-D neural probe for tinnitus

Study sheds new light on body's immune response to hepatitis A, C viruses

Insight into why some people develop drug addiction

Amylin to present data on investigational diabetes drug candidates at ADA annual meeting

Roundup: State employee benefit battles heat up; Wis. Gov. to remake Medicaid program; Mass. cost controls

Benitec’s pain program validated by independent study

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News